FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

PFIZER

4,370.65
-19.3 (-0.44%)
Updated 03:28 07/08 IST

PFIZER Buy or Sell - FrontPage Forums

1 Users have submitted 1 trade ideas of Rs. 22,075 for PFIZER
Disclaimer
100% Bullish
0% Bearish

PFIZER Buy or Sell - Brokerage Reports

No. of reports in last year
2
No. of analysts
2
Average Consensus Forecast
3978
Consensus Potential
-14.97%
See PFIZER Share Price Targets >>

PFIZER Ratings

Long term PFIZER rating by FrontPage users
4.5/5 (2 Ratings)
Find answers to all your questions on live PFIZER message board: Is PFIZER buy or sell? Should I buy PFIZER shares? Why are PFIZER shares falling? Should I invest in PFIZER stock?

  1. Home
  2. PFIZER Forum

PFIZER Share Price Discussion


Type
Buy
Instrument
PFIZER
Entry Price
₹4,415
Price@Trade
₹4,415
Target Price
₹7,000
Stop Price
₹2,000
Valid Till
Aug 6, 2021 3:20 AM
Margin
₹22,075 approx for 5 Qty
Status
Active
Like
Reply
N
Reputation: 4,689 • Aug 3 3:31 AM
Pricing Covid-19 vaccines too high could backfire on big pharmaceutical companies
A world without global intellectual property would be one of constant electronic warfare. State-backed hacking, such as China apparently tried with Moderna this week, would be a constant threat. Nor would companies enjoy a comfortable relationship with their own governments, who would see them less as engines of growth and more as storehouses of national wealth.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 30 5:41 AM
'Vaccine nationalism': Is it one country against other in the race for a Covid-19 shot?
That's the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.
The Economic Times
Like
Reply

*Pfizer Ltd.* | *CMP* Rs. 4371 | *M Cap* Rs. 19996 Cr | *52 W H/L* 4999/2612
(Nirmal Bang Retail Research)
*Result has improved*
Revenue from Operations came at Rs. 514.9 Cr (2.6% QoQ, -5.4% YoY) vs QoQ Rs. 502 Cr, YoY Rs. 544.4 Cr
EBIDTA came at Rs. 186.3 Cr (71.4% QoQ,...
Read more...
1
Reply

Type
Buy
Instrument
PFIZER
Entry Price
₹4,380.1
Price@Trade
₹4,380.1
Target Price
₹4,600
Stop Price
₹4,300
Valid Till
Aug 28, 2020 3:20 AM
Margin
₹87,602 approx for 20 Qty
Status
Stoploss Hit
Exit Price
₹4,300
Net P&L
-₹1,602 (-1.83%)
Like
Reply (2)
Latest replies
TrackerBot @trackerbot
Jul 29 7:55 AM

Update
Stoploss Hit
Exit Price
₹4,300
Anmol Khurana @anmolkhurana
Jul 29 1:36 AM

4200 ka sl rakh sakte hai for long??
N
Reputation: 4,689 • Jul 28 3:28 AM
Pfizer Standalone June 2020 Net Sales at Rs 514.89 crore, down 5.42% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 4,689 • Jul 27 3:33 AM
Pfizer Q1 net profit up 10% at Rs 124.45 crore
The company had posted a net profit of Rs 112.81 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a BSE filing.
Moneycontrol
Like
Reply
N
Reputation: 4,689 • Jul 25 2:56 AM
Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedy
In the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developments in both fronts, vaccines and drugs.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 23 2:21 AM
Asian markets mixed as US-China tensions offset stimulus hope
Optimism over the development of a vaccine and a wall of government and central bank cash is providing much-needed support to equities as traders fret over a spike in new infections around the world and the reimposition of containment measures in the US and other key economies.
The Economic Times
Like
Reply
US signs contract with Pfizer for Covid-19 vaccine doses
Health and Human Services Secretary Alex Azar announced on Wednesday that the US has signed a contract with Pfizer for delivery in December of the first 100 million doses of a Covid-19 vaccine the pha
@businessline
1
Reply
N
Reputation: 4,689 • Jul 20 4:36 AM
Oil steady as virus infections rise but hopes for vaccine lends support
Brent crude was down 6 cents, or 0.1%, at $43.08 per barrel by 11:34 a.m. ET (1534 GMT), while US West Texas Intermediate (WTI) was up 1 cent at $40.60.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 20 9:46 AM
Britain secures 90 million possible COVID-19 vaccine doses from Pfizer/BioNTech, Valneva
With no working vaccine against COVID-19 yet developed, Britain now has three different types of vaccine under order and a total of 230 million doses potentially available.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 20 6:53 AM
Buy Pfizer; target of Rs 4740: ICICI Direct
ICICI Direct is bullish on Pfizer recommended buy rating on the stock with a target price of Rs 4740 in its research report dated July 07, 2020.
Moneycontrol
Like
Reply
P
Reputation: 10,532 • Jul 14 2:35 AM

Bullish for next few days
PFIZER BUY ABOVE 4127
Target 4150/4160/4170
SL 4115
Astrazen BUY ABOVE 3341
Target 3360/3370/3380 SL 3330
ITI BUY ABOVE 132
Target 137/139/140
1
Reply
N
Reputation: 4,689 • Jul 13 10:36 AM
Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status - The Economic Times
Two experimental coronavirus vaccines jointly developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer have received 'fast track' designation from the U.S. drug regulator, the companies said on Monday.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 10 11:21 AM
Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end
The experimental vaccine, which showed promise against the fast-spreading respiratory illness in early stage human testing, is expected to move into a large trial involving 30,000 healthy participants later this month, pending regulatory nod.
The Economic Times
Like
Reply
N
Reputation: 4,689 • Jul 2 8:06 AM
Rupee posts biggest single day gain against dollar since April 23
The dollar index, which gauges the greenback's strength against a basket of six currencies, fell 0.35 per cent to 96.85.
The Economic Times
Like
Reply

Type
Sell
Instrument
PFIZER
Entry Price
₹4,136
Price@Trade
₹4,136
Target Price
₹3,863.7
Stop Price
₹4,265.55
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹99,264 approx for 24 Qty
Status
Exited
Exit Price
₹4,180.6
Net P&L
-₹1,070.4 (-1.08%)
Like
Reply (1)
Latest replies

Update
Exited
Exit Price
₹4,180.6
Net P&L
-₹1,070.4 (-1.08%)

Type
Sell
Instrument
PFIZER
Entry Price
₹4,166.1
Price@Trade
₹4,166.1
Target Price
₹3,912.1
Stop Price
₹4,285.45
Valid Till
Jul 2, 2020 3:20 AM
Margin
₹99,986.4 approx for 24 Qty
Status
Validity Over
Exit Price
₹4,185.4
Net P&L
-₹463.2 (-0.46%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jul 2 8:50 AM

Update
Validity Over
Exit Price
₹4,185.4
Net P&L
-₹463.2 (-0.46%)
L
Reputation: 10,468 • Jul 2 5:07 AM

PFIZER - chart - 975846
Pfizer chart NSE VS NYSE after vaccine news
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • PFIZER - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization15,274.76
    Enterprise Value13,362.42
    Price to Earnings27.77
    Price to Book Value5.07
    Return on Capital Employed0.2
    Return on Equity0.13
    Face Value10
    Dividend Yield0.01
  • PFIZER - Brokerage Reports

    keyboard_arrow_down
    DateBrokerageCallTarget
    31-Oct-19ICICIdirect.comBuy4,775
    13-Aug-19Nirmal BangAccumulate3,181
    9-May-18CentrumBuy2,900
    8-May-18ICICIdirect.comBuy3,000
    20-Dec-17ICICIdirect.comBuy2,444
    PFIZER Brokerage Price Target
  • PFIZER Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Aug 74394.954422.1543504383.5
    Aug 64450445343804389.95
    Aug 544154474.4544004424.85
    Aug 444204442.754366.054375.6
    Aug 34295443042774398.25
  • PFIZER Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹4,262.66
    30 Day Moving Average₹4,201.15
    50 Day Moving Average₹4,141.94
    100 Day Moving Average₹4,218.98
    200 Day Moving Average₹4,158
  • PFIZER - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,9691,966.270
    Operating Profit501350.120.43
    Profit Before Tax548516.840.06
    Net Income360336.780.07
  • PFIZER - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds3,0122,6830.12
    Total Liabilities9281,084-0.14
    Total Assets3,9403,7660.05
  • PFIZER - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity332328.80.01
    Cash from Investing Activity-238-249.68-0.05
    Cash from Financing Activity-110-82.590.33
    Net Cash Flow-17-3.473.9
  • PFIZER - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.10.1
    Return on Equity0.130.14
    Return on Capital Employed0.20.21
  • PFIZER - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.06
    3 Year CAGR Growth in Operating Profit0.65
    3 Year CAGR Growth in EBIDTA0.66
    3 Year CAGR Growth in Net Income2.59
    3 Yr CAGR Growth - Diluted EPS2.59
  • PFIZER - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.88
    5 Year CAGR Growth in Operating Profit1.72
    5 Year CAGR Growth in EBIDTA-0.13
    5 Year CAGR Growth in Net Income-0.28
    3 Yr CAGR Growth - Diluted EPS-0.53
  • PFIZER - Recent News

    keyboard_arrow_down
    NewsBot
    Jul 28 3:28 AM
    Pfizer Standalone June 2020 Net Sales at Rs 514.89 crore, down 5.42% Y-o-Y
    Moneycontrol
    NewsBot
    Jul 27 3:33 AM
    Pfizer Q1 net profit up 10% at Rs 124.45 crore
    Moneycontrol
    NewsBot
    Jul 23 2:21 AM
    Asian markets mixed as US-China tensions offset stimulus hope
    The Economic Times
    NewsBot
    Jul 20 4:36 AM
    Oil steady as virus infections rise but hopes for vaccine lends support
    The Economic Times
    NewsBot
    Jul 20 6:53 AM
    Buy Pfizer; target of Rs 4740: ICICI Direct
    Moneycontrol
    NewsBot
    Jul 13 10:36 AM
    Pfizer, BioNTech's coronavirus vaccine candidates get FDA's 'fast track' status - The Economic Times
    The Economic Times
    NewsBot
    Jul 10 11:21 AM
    Pfizer, BioNTech's COVID-19 vaccine expected to be ready for approval by year end
    The Economic Times
    NewsBot
    Jul 2 8:06 AM
    Rupee posts biggest single day gain against dollar since April 23
    The Economic Times
    NewsBot
    Jul 2 3:11 AM
    Gold prices today ease amid upbeat economic data, optimism over vaccine
    The Economic Times
    NewsBot
    Jul 2 2:36 AM
    Asian stocks rise on vaccine hopes, eyes on US payrolls
    The Economic Times
  • PFIZER - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020